10x Genomics Unlocks Whole Transcriptome Analysis in FFPE Tissues With New Visium Assay, Now Shipping

June 10, 2021 at 8:01 AM EDTPDF Version Fueling Discovery in Preserved Tissue Samples to Advance Clinical Translational Research PLEASANTON, Calif., June 10, 2021 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG) today announced it is shipping its new Visium Spatial Gene Expression for FFPE (formalin-fixed and paraffin-embedded) assay. The offering gives researchers access to the... Read more

LGC releases clinical diagnostic quality solution for SARS-CoV-2 variant analysis

LGC’s SeraCare has expanded its line of SARS-CoV-2 molecular quality solutions to include AccuPlex™ SARS-CoV-2 Variant Panel 1. The kit contains full SARS-CoV-2 genomic RNA with a focus on S-gene mutations in three prominent variants of concern (UK variant B.1.1.7, South Africa variant B.1.351, and Brazil variant P.1) with vials for each variant as well as... Read more

New hard drinking water reference material from NML at LGC traceable to the SI for

The UK’s National Measurement Laboratory (NML), hosted at LGC, is pleased to announce the launch of a new certified reference material, LGC6028 Hard drinking water – metals (lower levels), with values traceable to the SI (International System of Units). The elements present in drinking water are regulated through legislation. These limits ensure the water is safe for... Read more

Waters Sets New Standard in High Resolution Mass Spectrometry with SELECT SERIES Multi Reflecting Time-of-Flight Platform

06/08/21 New Multi Reflecting Time-of-Flight (MRT) mass spectrometry platform from Waters delivers highest quality resolution at fast speedsi. Exceptional clarity of molecular structures and location in tissues for spatial-omics applications with enhanced Desorption Electrospray Ionization (DESI) and new Matrix-Assisted Laser Desorption Ionization (MALDI) imaging sources. Waters SELECT SERIES MRT platform to serve as basis for... Read more

Thermo Fisher Scientific Launches Ion AmpliSeq SARS-CoV-2 Insight Research Assay for SARS-CoV-2 Surveillance

Thermo Fisher Scientific Launches Ion AmpliSeq SARS-CoV-2 Insight Research Assay for SARS-CoV-2 Surveillance Panel enables early identification of new and known variants from a variety of sample types CARLSBAD, Calif., June 7, 2021 /PRNewswire/ — Thermo Fisher Scientific today introduced the Ion AmpliSeq SARS-CoV-2 Insight Research Assay to improve SARS-CoV-2 surveillance. The assay is designed to enable... Read more

Thermo Fisher Scientific Launches Novel Flow Cytometer with Imaging Capability

Invitrogen Attune CytPix Flow Cytometer* enables researchers and cell therapy developers to collect fluorescent data and high resolution images CARLSBAD, Calif., June 7, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the Invitrogen Attune CytPix Flow Cytometer, an imaging-enhanced flow cytometer that combines acoustic focusing flow... Read more

Thermo Fisher Scientific and Newomics Develop New Approaches to LC-MS Analysis of Native Protein Complexes

Thermo Fisher Scientific and Newomics Develop New Approaches to LC-MS Analysis of Native Protein Complexes SAN JOSE, Calif., June 7, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, and Newomics a commercial-stage biotechnology company, are collaborating to develop a novel native liquid chromatography-mass spectrometry (LC−MS) platform to support various LC−MS applications. This... Read more

Bruker Launches CE-IVD Quantitative Coronavirus Mid-Plex PCR Assay with Mutation Detection for Routine Variant Differentiation

FluoroType® SARS-CoV-2 varID Q is a novel LiquidArray® mid-plex PCR panel Detection of selected SARS-CoV-2 mutations enables differentiation of major viral variants, or strains, without the costs and delays of selective NGS for variant epidemiology Quantification of viral load provides indication of infectivity and of stage of COVID infection Validated with nasopharyngeal swabs and oropharyngeal... Read more

Agilent Announces New SureSelect Human All Exon V8

Design provides comprehensive content and flexible exome options SANTA CLARA, Calif., June 02, 2021  Agilent Technologies Inc. (NYSE: A) today announced the release of SureSelect Human All Exon V8 – a new exome design that provides comprehensive content and up-to-date coverage of protein-coding regions from RefSeq, CCDS, and GENCODE. It also covers the TERT promoter and hard-to-capture... Read more